Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma

Clinical and Experimental Ophthalmology

Volumn 40, Issue 7, 2012, Pages 736-742

  Narang, Subina ^a   Mashayekhi, Arman ^b   Rudich, Danielle ^b   Shields, Carol L ^b  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Chemoreduction; Intraocular retinoblastoma; Visual outcome

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CHILD; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTIPLE CANCER; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETINOBLASTOMA; RETROSPECTIVE STUDY; VISUAL ACUITY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD, PRESCHOOL; ETOPOSIDE; FOLLOW-UP STUDIES; HUMANS; INFANT; MULTIVARIATE ANALYSIS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINCRISTINE; VISUAL ACUITY;

EID: 84867396888     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2012.02757.x     Document Type: Article

References (27)

1. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol 2010; 21: 203-12.
2. Kim JW, Abrahmson DH, Dunkel IJ. Current management strategies in intraocular retinoblastomas. Drugs 2007; 67: 2173-5.
3. Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control 2004; 11: 317-27.
4. Epstein JA, Shields CL, Shields JA. Trends in management of retinoblastoma: evaluation of 1196 consecutive eyes during 1974 to 2001. J Pediatr Ophthalmol Strabismus 2003; 40: 196-203.
5. Gunduz K, Shields CL, Shields JA etal. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Arch Ophthalmol 1998; 116: 1613-17.
6. Shields CL, Potter PD, Himelstein BP etal. Chemoreduction in initial management of intraocular retinoblastoma. Arch Ophthalmol 1996; 114: 1330-8.
7. Shields CL, Mashayekhi A, Cater J etal. Chemoreduction for retinoblastoma. Analysis of tumour control and risks for recurrence in 457 tumours. Am J Ophthalmol 2004; 13: 329-37.
8. Shields CL, Honavar SG, Shields JA etal. Factors predictive of recurrence of retinal tumors, vitreous seeds and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002; 120: 460-4.
9. Shields CL, Honavar SG, Shields JA etal. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with EBRT or enucleation. Am J Ophthalmol 2002; 133: 657-64.
10. Eng C, Li FP, Abramson DH etal. Mortality from second tumors among long term survivors of retinoblastoma. J Natl Cancer Inst 1993; 85: 1121-8.
11. Abramson DH, Jereb B, Ellsworth RM. External beam radiation for retinoblastoma. Bull N Y Acad Med 1981; 57: 787-803.
12. Fontanesi J, Pratt CB, Kun LE etal. Treatment outcome and dose-response relationship in infants younger than 1year treated for retinoblastoma with primary irradiation. Med Pediatr Oncol 1996; 26: 297-304.
13. Foote RL, Garretson BR, Schomberg PJ etal. External beam irradiation for retinoblastoma: patterns of failure and dose response analysis. Int J Radiat Oncol Biol Phys 1989; 16: 823-30.
14. Lambert MP, Shields C, Meadows AT. A retrospective review of hearing in children with retinoblastoma treated with carboplatin based chemotherapy. Pediatr Blood Cancer 2008; 50: 223-6.
15. Rizzuti AE, Dunkel IJ, Abramson DH. The adverse effects of chemotherapy for retinoblastoma [Editorial]. Arch Ophthalmol 2008; 126: 862-5.
16. Gombos DS, Hungerford J, Abramson DH etal. Secondary acute myeloid leukaemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology 2007; 114: 1378-83.
17. Demirci SCL, Meadows AT, Shields JA. Long-term visual outcome following chemoreduction for retinoblastoma. Arch Ophthalmol 2005; 123: 1525-30.
18. Desjardin L, Chefchaouni MC, Lumbroso L etal. Functional results after treatment of retinoblastoma. J AAPOS 2002; 6: 108-11.
19. Kingston JE, Hungerford JL, Madreperla SA, Plowmen PN. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 1996; 114: 1339-47.
20. Chan MP, Hungerford JL, Kingston JE, Plowman PN. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Br J Ophthalmol 2009; 93: 891-4.
21. Migdal C. Bilateral retinoblastoma: the prognosis for vision. Br J Ophthalmol 1983; 67: 592-5.
22. Hall LS, Ceisler E, Abramson DH. Visual outcome in children with bilateral retinoblastoma. J AAPOS 1999; 3: 138-42.
23. Gombos DS, Kelly A, Coen PG etal. Retinoblastoma treated with primary chemotherapy alone: the significance of tumor size, location, and age. Br J Ophthalmol 2002; 86: 80-4.
24. Wetts P, Westall C, Colpa L etal. Visual results in children treated for macular retinoblastoma. Eye 2002; 16: 75-80.
25. Shields CL, Mashayekhi A, Cater J etal. Macular retinoblastoma managed with chemoreduction. Analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Arch Ophthalmol 2005; 123: 765-73.
26. Ek U, Seregard S, Jacabson L, Oskar K, Af Trampe E, Kock E. A prospective study of children treated for retinoblastoma: cognitive and visual outcome in relation treatment. Acta Ophthalmol Scand 2002; 80: 294-9.
27. Desjardins L, Chefchaouni MC, Lumbroso L, Levy C. Functional results of retinoblastoma treatment with local treatment used in isolation or associated with chemotherapy. J Fr Ophtalmol 2005; 28: 725-31.